Stellular Bio
Cambridge, United States· Est.
We aim to improve the lives of patients with ocular surface disease (OSD) with our pioneering platelet-derived regenerative biologic (PRB) therapy.
Private Company
Total funding raised: $4.5M
About
We aim to improve the lives of patients with ocular surface disease (OSD) with our pioneering platelet-derived regenerative biologic (PRB) therapy.
Biologics
Funding History
1Total raised:$4.5M
Seed$4.5M